Answers are grounded in this paper and cite their sources.
Background Although outcomes of patients supported with venovenous extracorporeal membrane oxygenation (ECMO) are well documented, outcomes of those who are referred but do not undergo cannulation remain limited. Research Question Among patients with COVID-19-related ARDS referred for venovenous ECMO, how do outcomes compare between those who undergo cannulation and those who do not? Study Design and Methods This single-center retrospective study of a prospective registry evaluated all adult patients with COVID-19-related ARDS who underwent venovenous ECMO consultation through a multidisciplinary approach between March 2020 and October 2022. The primary outcome was 90-day survival after ECMO consultation, comparing cannulated patients with a propensity-matched noncannulated cohort. Secondary outcomes included unadjusted 90-day survival and survival to hospital discharge with and without Respiratory ECMO Survival Prediction (RESP) score stratification. For propensity score matching, covariates were age, pH, Paco 2 , Pao 2 to Fio 2 ratio, acute kidney injury, vasopressor or inotropic requirement, and RESP score. Results Of 247 patients referred for venovenous ECMO, 90-day survival after ECMO consultation—the primary outcome—was higher in the cannulated group (n = 86) than the propensity-matched noncannulated group (n = 86; 48.8% vs 23.3%; hazard ratio, 0.40 [95% CI, 0.28-0.59]; P < .001). Secondary analyses demonstrated similar findings: unadjusted 90-day survival was 48.8% vs 15.5% (hazard ratio, 0.31 [95% CI, 0.22-0.43]; P < .001), and survival to hospital discharge in matched cohorts was 43.0% vs 24.4% ( P < .001). When stratified by RESP scores, survival to discharge for the so-called sick patients remained higher among cannulated patients (RESP score of 3 to 5: 63.6% vs 19.3% [ P < .001]; RESP score of –1 to 2, 28.6% vs 7.8% [ P = .016]). Interpretation Our results show that among select patients with severe COVID-19-related ARDS referred for venovenous ECMO, cannulation was associated with higher observed survival. However, despite matching, residual confounding—particularly from clinical judgement factors affecting cannulation decisions—limits causal inference. These findings underscore the need for cautious interpretation and further prospective studies to better define ECMO candidacy and outcomes.
No takes yet. Share an insight, caveat, or question.
Dinh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: